Efficacy and safety of a bolus of half-dose r-SAK prior to primary PCI in ST-elevation myocardial infarction: Rationale and design of the OPTIMA-6 trial.
Li C, Eikelboom JW, Zhong Z, Zhang X, Liu K, Zhu L, Yang N, Chen X, Wang X, Zhao X, Jiang J, Pu J, Zhao B, Zhang F, Zhu J, Huang J, Kong X, Yu H, Tan C, Zhang W, Wang Q, Gong X, Bai J, Li C; Nanjing, China.
Li C, et al.
Am Heart J. 2023 Nov;265:31-39. doi: 10.1016/j.ahj.2023.06.012. Epub 2023 Jun 25.
Am Heart J. 2023.
PMID: 37369268